Edwards Lifesciences Corporation logo
EWEdwards Lifesciences Corporation

EV/EBITDA Ratio: 26.80x

popular:market cap|pe ratio|revenue|price history|total return

Is the EV/EBITDA ratio high or low?

The EV/EBITDA ratio of 26.80x is 11% below its 5-year average of 30.14x, near the low end of its 5-year range (21.42x–47.63x).

As of Sunday, June 28, 2026. 1.35% above its 12-month average of 26.44x.

EV/Sales|P/E Ratio|EBITDA|All Metrics
EV/EBITDA Ratio

EW EV/EBITDA Ratio Chart

26.80x
-1.58% 1Y
EW EV/EBITDA Ratio

EW Average EV/EBITDA Ratio Chart

EW EV/EBITDA Ratio

EW Current vs Average EV/EBITDA Ratio Chart

EW EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

26.80x

EV/EBITDA RATIO AVG TTM

26.44x

EV/EBITDA RATIO AVG 3Y

26.10x

EV/EBITDA RATIO AVG 5Y

29.77x

EV/EBITDA RATIO AVG 10Y

30.76x

EV/EBITDA RATIO AVG 15Y

28.14x

EV/EBITDA RATIO AVG 20Y

25.34x

CURRENT VS TTM AVG

+1.35%

CURRENT VS 3Y AVG

+2.70%

CURRENT VS 5Y AVG

-9.96%

CURRENT VS 10Y AVG

-12.88%

CURRENT VS 15Y AVG

-4.76%

CURRENT VS 20Y AVG

+5.76%

EW Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
Edwards Lifesciences Corporation (EW)$52.27B26.80x26.44x26.10x29.77x
Cencora, Inc. (COR)vs ›$55.67B12.61x14.55x13.54x12.07x
Cardinal Health, Inc. (CAH)vs ›$55.72B19.30x15.85x15.63x29.80x
Becton, Dickinson and Company (BDX)vs ›$56.49B12.96x12.53x14.56x15.02x
Humana Inc. (HUM)vs ›$46.08B25.31x15.20x13.67x14.23x
IDEXX Laboratories, Inc. (IDXX)vs ›$43.50B29.20x35.64x34.55x38.17x
Regeneron Pharmaceuticals, Inc. (REGN)vs ›$65.20B16.29x17.16x19.57x16.20x
Boston Scientific Corporation (BSX)vs ›$65.74B13.65x29.42x32.26x29.80x
Agilent Technologies, Inc. (A)vs ›$38.41B21.93x21.96x22.80x23.85x
Medline Inc. (MDLN)vs ›$32.87B14.24x14.71x14.71x14.71x

EV/EBITDA vs. its own history

At 26.8, EV/EBITDA is in its normal range, sitting higher than 59% of its 20-year history.

20-year low

11.0

median

25.7

20-year high

47.6

cheaperricher

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Edwards Lifesciences Corporation (EW)?
The EV/EBITDA ratio for EW stock is 26.80x.
Is Edwards Lifesciences Corporation's EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 26.80x is 11% below its 5-year average of 30.14x, near the low end of its 5-year range (21.42x–47.63x).
What is the TTM average EV/EBITDA ratio for Edwards Lifesciences Corporation (EW)?
The TTM average EV/EBITDA ratio for EW stock is 26.44x.
What is the 3Y average EV/EBITDA ratio for Edwards Lifesciences Corporation (EW)?
The 3Y average EV/EBITDA ratio for EW stock is 26.10x.
What is the 5Y average EV/EBITDA ratio for Edwards Lifesciences Corporation (EW)?
The 5Y average EV/EBITDA ratio for EW stock is 29.77x.
What is the 10Y average EV/EBITDA ratio for Edwards Lifesciences Corporation (EW)?
The 10Y average EV/EBITDA ratio for EW stock is 30.76x.
What is the 15Y average EV/EBITDA ratio for Edwards Lifesciences Corporation (EW)?
The 15Y average EV/EBITDA ratio for EW stock is 28.14x.
What is the 20Y average EV/EBITDA ratio for Edwards Lifesciences Corporation (EW)?
The 20Y average EV/EBITDA ratio for EW stock is 25.34x.

EW EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-06-2626.80x
2026-06-2526.48x
2026-06-2426.46x
2026-06-2325.63x
2026-06-2225.30x
2026-06-1825.76x
2026-06-1725.55x
2026-06-1626.13x
2026-06-1525.43x
2026-06-1225.07x
2026-06-1125.27x
2026-06-1025.34x
2026-06-0925.81x
2026-06-0825.30x
2026-06-0525.33x
2026-06-0425.78x
2026-06-0325.34x
2026-06-0225.85x
2026-06-0126.00x
2026-05-2925.48x
2026-05-2825.33x
2026-05-2725.50x
2026-05-2625.81x
2026-05-2225.27x
2026-05-2124.49x
2026-05-2024.42x
2026-05-1924.17x
2026-05-1824.24x
2026-05-1523.93x
2026-05-1423.92x
2026-05-1323.93x
2026-05-1223.43x
2026-05-1122.65x
2026-05-0823.50x
2026-05-0724.35x
2026-05-0624.49x
2026-05-0525.88x
2026-05-0426.02x
2026-05-0126.23x
2026-04-3026.07x
2026-04-2925.33x
2026-04-2825.67x
2026-04-2726.06x
2026-04-2426.28x
2026-04-2324.83x
2026-04-2225.43x
2026-04-2124.83x
2026-04-2025.40x
2026-04-1725.25x
2026-04-1624.62x
2026-04-1524.34x
2026-04-1424.34x
2026-04-1324.31x
2026-04-1024.23x
2026-04-0924.65x
2026-04-0825.49x
2026-04-0725.20x
2026-04-0625.32x
2026-04-0225.27x
2026-04-0125.34x
2026-03-3124.95x
2026-03-3024.76x
2026-03-2724.71x
2026-03-2625.61x
2026-03-2525.80x
2026-03-2425.48x
2026-03-2325.59x
2026-03-2025.74x
2026-03-1925.73x
2026-03-1825.78x
2026-03-1726.32x
2026-03-1626.09x
2026-03-1325.52x
2026-03-1226.44x
2026-03-1126.59x
2026-03-1026.82x
2026-03-0926.32x
2026-03-0625.46x
2026-03-0526.20x
2026-03-0426.63x
2026-03-0326.65x
2026-03-0227.28x
2026-02-2727.04x
2026-02-2626.86x
2026-02-2526.04x
2026-02-2426.91x
2026-02-2326.92x
2026-02-2026.01x
2026-02-1925.72x
2026-02-1825.74x
2026-02-1725.56x
2026-02-1324.68x
2026-02-1224.88x
2026-02-1125.86x
2026-02-1025.08x
2026-02-0925.00x
2026-02-0625.65x
2026-02-0525.44x
2026-02-0426.01x
2026-02-0326.80x
2026-02-0226.99x
2026-01-3026.55x
2026-01-2926.60x
2026-01-2826.72x
2026-01-2727.32x
2026-01-2627.54x
2026-01-2327.34x
2026-01-2227.60x
2026-01-2127.84x
2026-01-2027.27x
2026-01-1627.57x
2026-01-1527.62x
2026-01-1427.14x
2026-01-1327.40x
2026-01-1227.11x
2026-01-0927.84x
2026-01-0827.65x
2026-01-0727.73x
2026-01-0628.08x
2026-01-0527.51x
2026-01-0227.90x
2025-12-3127.88x
2025-12-3028.20x
2025-12-2928.45x
2025-12-2628.42x
2025-12-2428.23x
2025-12-2328.21x
2025-12-2228.31x
2025-12-1928.02x
2025-12-1827.72x
2025-12-1727.74x
2025-12-1627.90x
2025-12-1527.24x
2025-12-1227.14x
2025-12-1127.53x
2025-12-1027.42x
2025-12-0927.21x
2025-12-0827.56x
2025-12-0528.20x
2025-12-0428.06x
2025-12-0327.44x
2025-12-0227.69x
2025-12-0127.88x
2025-11-2828.36x
2025-11-2628.39x
2025-11-2528.41x
2025-11-2427.69x
2025-11-2127.84x
2025-11-2027.48x
2025-11-1928.14x
2025-11-1827.46x
2025-11-1727.70x
2025-11-1428.23x
2025-11-1328.17x
2025-11-1227.99x
2025-11-1127.85x
2025-11-1027.48x
2025-11-0727.24x
2025-11-0626.92x
2025-11-0527.06x
2025-11-0428.59x
2025-11-0328.20x
2025-10-3127.98x
2025-10-3028.35x
2025-10-2928.06x
2025-10-2827.88x
2025-10-2727.39x
2025-10-2425.70x
2025-10-2325.86x
2025-10-2225.97x
2025-10-2125.67x
2025-10-2025.41x
2025-10-1725.18x
2025-10-1624.47x
2025-10-1524.57x
2025-10-1424.72x
2025-10-1324.57x
2025-10-1024.93x
2025-10-0925.38x
2025-10-0825.57x
2025-10-0725.92x
2025-10-0625.87x
2025-10-0326.05x
2025-10-0225.90x
2025-10-0125.78x
2025-09-3026.30x
2025-09-2926.09x
2025-09-2625.76x
2025-09-2525.40x
2025-09-2425.19x
2025-09-2325.15x
2025-09-2224.86x
2025-09-1925.10x
2025-09-1825.15x
2025-09-1725.38x
2025-09-1625.34x
2025-09-1525.68x
2025-09-1226.23x
2025-09-1126.39x
2025-09-1026.48x
2025-09-0927.03x
2025-09-0827.17x
2025-09-0527.44x
2025-09-0427.44x
2025-09-0327.54x
2025-09-0227.73x
2025-08-2927.58x
2025-08-2827.54x
2025-08-2727.42x
2025-08-2627.55x
2025-08-2527.41x
2025-08-2227.76x
2025-08-2127.51x
2025-08-2027.60x
2025-08-1926.72x
2025-08-1826.49x
2025-08-1526.48x
2025-08-1426.45x
2025-08-1326.27x
2025-08-1226.00x
2025-08-1126.44x
2025-08-0826.51x
2025-08-0726.36x
2025-08-0626.60x
2025-08-0528.01x
2025-08-0428.32x
2025-08-0128.04x
2025-07-3128.03x
2025-07-3028.72x
2025-07-2928.46x
2025-07-2827.73x
2025-07-2528.29x
2025-07-2426.72x
2025-07-2327.14x
2025-07-2226.91x
2025-07-2127.01x
2025-07-1826.98x
2025-07-1726.86x
2025-07-1626.85x
2025-07-1527.10x
2025-07-1427.65x
2025-07-1127.56x
2025-07-1027.84x
2025-07-0927.24x
2025-07-0826.94x
2025-07-0727.05x
2025-07-0327.09x
2025-07-0227.18x
2025-07-0127.24x
2025-06-3027.62x
2025-06-2727.62x
2025-06-2627.23x
2025-06-2527.16x
2025-06-2426.74x
2025-06-2326.54x
2025-06-2025.99x
2025-06-1826.04x
2025-06-1725.78x
2025-06-1626.36x
2025-06-1326.48x

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

Related Metrics

EV/SalesP/E RatioEBITDAAll Metrics

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Irvine, CA
15,800 employees
www.edwards.com
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian
View full financials